Filing Details
- Accession Number:
- 0000905718-20-001131
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-23 11:14:02
- Reporting Period:
- 2020-11-19
- Accepted Time:
- 2020-11-23 11:14:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1566373 | F-Star Therapeutics Inc. | SBPH | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1339402 | J Martin Driscoll | C/O Spring Bank Pharmaceuticals, Inc. 35 Parkwood Drive, Suite 210 Hopkinton MA 01748 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-19 | 10,000 | $0.00 | 32,600 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-11-19 | 15,000 | $0.00 | 47,600 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2020-11-20 | 175 | $4.76 | 47,425 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2020-11-19 | 10,000 | $0.00 | 10,000 | $0.00 |
| Common Stock | Warrants | Disposition | 2020-11-19 | 5,475 | $0.00 | 5,475 | $43.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 0 | 2017-05-24 | 2021-11-23 | No | 4 | J | Direct |
Footnotes
- Restricted stock units ("RSUs") converted into common stock on a one-for-one basis.
- All unvested issued and outstanding RSUs accelerated and vested in full in connection with the closing of the business combination with F-star Therapeutics Limited.
- The reported securities were called for redemption by the Issuer at their Black-Scholes value.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.64 to $4.88 per share. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
Billionaire Hedge Funds
